EFTA01951579.pdf

To: Boris Nikoli From: Jeffrey Epstein Sent Wed 10/30/2013 9:12:59 PM Subject: Re: let me know how did it go i wrote this for them not for you, On Wed, Oct 30, 2013 at 4:56 PM, Boris Nikolic wrote: I get it overall — but I still do not get some details. To start with your example — "if foundation medicine is only worth a total of 25 million, then 15 million is profit, 5 has already been advanced, you are owed 10". My question- And this ten goes as a credit against his new 10 that he would place into fund? I do not get any money from that distribution but only after a fund was paid off (The investment period of the 1ST Fund will be [4-5] years with a 10 year fund life). And he gets all profits on this ten? If this is correct — this deal is even worse for me — as for example I could take 10 that I would be owned from FM and invest. However, this is a price for having his name on? Right now, 5M advance will be deducted from the LAST call (in slightly less than 3 years). Can you structure that possible 10M fund credit would be deducted from the last draw? Sorry if I got it wrong! Thank you Boris EFTA_R1_00418717 EFTA01951579 From: Jeffrey Epstein [[email protected]] Sent: Wednesday, October 30, 2013 1:35 PM To: Boris Nikolic Subject: Re: let me know how did it go proposal I, bill invests a new 10 million in the fund. the upside is all his the first 10 millon is yours. it is to be used as a credit, if it goes down boris eats it. if it goes up, bill gets the profits. our deal remains the same, foundation medicne and the totals to both parties are unchanged. for example,. if foundation medicine is only worth a total of 25 million , then 15 million is profit, five has already been advanced, you are owed ten. if the fund piece above ten you get it, if it is below the loss below ten is yours. . On Wed, Oct 30, 2013 at 3:54 PM, Boris Nikolic wrote: The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for EFTA_R1_00418718 EFTA01951580 the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected] and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00418719 EFTA01951581